Lineage Cell Therapeutics Inc
(STU:BT3)
€
1.11
-0.016 (-1.42%)
Market Cap: 280.21 Mil
Enterprise Value: 234.41 Mil
PE Ratio: 0
PB Ratio: 5.93
GF Score: 78/100 Lineage Cell Therapeutics Inc (STU:BT3) Transcripts
- 1